The effect of grapefruit juice on drug disposition

MJ Hanley, P Cancalon, WW Widmer… - Expert opinion on drug …, 2011 - Taylor & Francis
Introduction: Since their initial discovery in 1989, grapefruit juice (GFJ)–drug interactions
have received extensive interest from the scientific, medical, regulatory and lay communities …

Understanding and preventing drug interactions in elderly patients

JC Delafuente - Critical reviews in oncology/hematology, 2003 - Elsevier
The elderly consume a disproportionate amount of prescription and nonprescription
medications. Alterations in physiology, polypharmacy, multiple prescribers, and other factors …

Food–drug interaction: grapefruit juice augments drug bioavailability—mechanism, extent and relevance

A Dahan, H Altman - European journal of clinical nutrition, 2004 - nature.com
More than a decade has passed since it was unintentionally discovered that grapefruit juice
interacts with certain drugs. The coadministration of these drugs with grapefruit juice can …

Interactions between grapefruit juice and cardiovascular drugs

DDG Bailey, GK Dresser - American Journal of Cardiovascular Drugs, 2004 - Springer
Grapefruit juice can alter oral drug pharmacokinetics by different mechanisms. Irreversible
inactivation of intestinal cytochrome P450 (CYP) 3A4 is produced by commercial grapefruit …

Grapefruit-drug interactions

K Seden, L Dickinson, S Khoo, D Back - Drugs, 2010 - Springer
Grapefruit juice and grapefruit product consumption have potential health benefits; however,
their intake is also associated with interactions with certain drugs, including calcium channel …

Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration

C Ulbricht, W Chao, D Costa… - Current drug …, 2008 - ingentaconnect.com
To evaluate the pharmacokinetics and adverse effects of medicinal herbs, as well as clinical
evidence of herb-drug interactions. Electronic searches were conducted in multiple …

Phosphodiesterase type 5 inhibitors for erectile dysfunction

CC Carson, TF Lue - BJU international, 2005 - Wiley Online Library
This is our first presentation of Great Drug Classes, and we start with a description of
phosphodiesterase type 5 inhibitors and their use in erectile dysfunction. This is an in‐depth …

The efficacy and safety of tadalafil: an update

CC Carson, J Rajfer, I Eardley, S Carrier… - BJU …, 2004 - Wiley Online Library
OBJECTIVE To provide an update on the efficacy and safety of tadalafil, a
phosphodiesterase‐5 inhibitor, in the treatment of erectile dysfunction (ED). PATIENTS AND …

The clinical pharmacokinetics of phosphodiesterase‐5 inhibitors for erectile dysfunction

M Gupta, A Kovar, B Meibohm - The Journal of Clinical …, 2005 - Wiley Online Library
Differences in the clinical pharmacology of the 3 currently available oral phosphodiesterase‐
5 (PDE5) inhibitors, sildenafil, vardenafil, and tadalafil, are largely determined by their …

Herbal remedies and clinical biochemistry

CM Corns - Annals of clinical biochemistry, 2003 - journals.sagepub.com
The use of herbal products in the UK is increasing, and over-the-counter herbal
supplements are perceived by the public as' safe'and'harmless'. Although the majority of …